# Epocrates

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epocrates

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.epocrates.com
- Total disclosed funding: $41M
- Latest round: Series C (Oct 12, 2004)
- Investors on record: 5

## About

Epocrates, Inc. delivers digital healthcare solutions that empower healthcare professionals with essential medical information, enhancing decision-making and patient care quality.Founded in 1998, Epocrates, Inc. operates in San Francisco, US, providing mobile healthcare solutions. The company went public in February 2011, raising USD 85.76 mn through its IPO. In January 2013, Epocrates was acquired by Athenahealth, Inc. for USD 293 mn. The founder's history is not explicitly provided, nor does it mention any subsidiaries.Epocrates offers a comprehensive suite of digital healthcare solutions, featuring a mobile app that provides healthcare professionals access to a vast database of medical information, including drug interactions and clinical guidelines. Its platform supports physicians, pharmacists, and other healthcare providers, particularly in emergency and primary care settings, facilitating informed treatment decisions across North America and other expanding markets.In the most recent year, 2012, Epocrates reported a revenue of USD 111.13 mn and an EBITDA of USD 7.87 mn. The company generates income through subscription services and partnerships with healthcare institutions and pharmaceutical companies, offering premium app features and B2B collaborations.Following its IPO in February 2011, which raised USD 85.76 mn, Epocrates aims to leverage its funding for strategic growth. The company focuses on designing new product features to enhance user experience and anticipates expanding into European markets by 2015, capitalizing on partnerships with pharmaceutical companies to bolster its offerings. The acquisition by Athenahealth in January 2013 for USD 293 mn is expected to enhance Epocrates’ capabilities and outreach.

## Funding rounds

- Series C, Oct 12, 2004, $0.4M — Draper Fisher Jurvetson, InterWest Partners, Sprout Group, Three Arch Partners, Bay City Capital
- Series C, Jun 28, 2002, $6M — Draper Fisher Jurvetson, InterWest Partners, Sprout Group, Three Arch Partners, Bay City Capital
- Series B, Aug 17, 2000, $35M — Draper Fisher Jurvetson, InterWest Partners, Sprout Group, Three Arch Partners, Bay City Capital

## Investors

- Draper Fisher Jurvetson (https://capitalatlas.ai/funds/draper-fisher-jurvetson) — Series B, Series C
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series B, Series C
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series B, Series C
- Three Arch Partners (https://capitalatlas.ai/funds/three-arch-partners) — Series B, Series C
- Bay City Capital (https://capitalatlas.ai/funds/bay-city-capital) — Series B, Series C